Several executives at Nashville, Tenn.-based HCA Healthcare recently sold shares of the company's stock, according to Securities and Exchange Commission filings.
HCA, one of the largest for-profit hospital operators in the U.S., reported a net income of nearly $1.5 billion in the second quarter of 2024, up from $1.2 billion over the same period a year earlier.
Below are four HCA executives' stock transaction activities since July 25, according to the SEC filings:
1. Chris Wyatt, senior vice president and controller, sold 4,000 shares of the company's stock on July 29 for a total price of $1,440,783.
2. Kathi Whalen, senior vice president and chief ethics and compliance officer, sold 1,864 shares of the company's stock July 29 for a total price of $670,890.88.
3. Deborah Reiner, senior vice president of marketing and corporate affairs, sold 3,314 shares of the company's stock July 29 for a total price of $1,192,914.40.
4. Kathryn Torres, senior vice president of payer contracting and alignment, sold 1,857 shares of the company's stock July 25 for a total price of $659,327.85.